Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα-Reference-Cited by-同舟云学术

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

Published:2022-02 Issue:2 Volume:162 Page:454-467
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Edelman-Klapper Hadar^ORCID,Zittan Eran,Bar-Gil Shitrit Ariella,Rabinowitz Keren Masha,Goren Idan,Avni-Biron Irit,Ollech Jacob E.,Lichtenstein Lev,Banai-Eran Hagar,Yanai Henit,Snir Yifat,Pauker Maor H.,Friedenberg Adi,Levy-Barda Adva,Segal Arie,Broitman Yelena,Maoz Eran,Ovadia Baruch,Golan Maya Aharoni,Shachar Eyal,Ben-Horin Shomron,Perets Tsachi-Tsadok,Ben Zvi Haim,Eliakim Rami,Barkan Revital,Goren Sophy,Navon Michal,Krugliak Noy,Werbner Michal,Alter Joel,Dessau Moshe,Gal-Tanamy Meital,Freund Natalia T.,Cohen Dani,Dotan Iris

Funder

Leona M and Harry B Helmsley Charitable Trust

Israel Science Foundation

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference53 articles.

1. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim Guidance. World Health Organization; 2020.

2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

3. An mRNA vaccine against SARS-CoV-2 — preliminary report;Jackson;N Engl J Med,2020

4. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease;Rahier;J Crohn’s Colitis,2014

5. Evidence-based clinical practice guidelines for inflammatory bowel disease;Matsuoka;J Gastroenterol,2018

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study;eBioMedicine;2024-10

2. Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease;Vaccines;2024-07-15

3. Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study;ACR Open Rheumatology;2024-07

4. COVID-19 vaccination safety and associated health care utilization among adults with inflammatory bowel disease – a population-based self-controlled case series analysis;BMC Gastroenterology;2024-05-30

5. Vaccine adherence and adverse events of the SARS-COV vaccine in patients with inflammatory bowel disease;Gastroenterología y Hepatología;2024-05